1228 CANbridge Pharmaceuticals Inc. HKEX · China

CANbridge Pharmaceuticals (1228) news

CANbridge Pharmaceuticals Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1228, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest CANbridge Pharmaceuticals news

We have not published a story on CANbridge Pharmaceuticals yet. When there is news, it will appear here.

Questions about CANbridge Pharmaceuticals

What is the ticker symbol of CANbridge Pharmaceuticals?

CANbridge Pharmaceuticals Inc. trades under the ticker 1228 on HKEX.

Where is CANbridge Pharmaceuticals listed?

CANbridge Pharmaceuticals Inc. is listed on HKEX.

Which country or territory is CANbridge Pharmaceuticals listed under?

Our directory records CANbridge Pharmaceuticals Inc. under China.

What does CANbridge Pharmaceuticals do?

Our directory classifies CANbridge Pharmaceuticals Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of CANbridge Pharmaceuticals?

The ISIN recorded for CANbridge Pharmaceuticals Inc. is KYG1821D1097.

Does aibio.space cover CANbridge Pharmaceuticals?

aibio.space lists CANbridge Pharmaceuticals Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to CANbridge Pharmaceuticals?

Companies in our directory listed in the same country and business area as CANbridge Pharmaceuticals: Shanghai Junshi Biosciences Co., VISEN Pharmaceuticals, InnoCare Pharma, Gansu Longshenrongfa Pharmaceutical Industry Co., China Medical System Holdings, Henan Lingrui Pharmaceutial Co..

Investor discussion: CANbridge Pharmaceuticals

Members talk about CANbridge Pharmaceuticals (1228). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at CANbridge Pharmaceuticals, newest first. Each line links the filing it comes from.

Jun 2, 2026Financings
Share or debt issue: (1) PROPOSED GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; (4) PROPOSED GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS; AND (5) NOTICE OF AGM. Source
Mar 10, 2026Financings
Share or debt issue: COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. Source
Feb 15, 2026Financings
Share or debt issue: SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. Source
Nov 19, 2025Financings
Share or debt issue: PROPOSED REFRESHMENT OF GENERAL MANDATE AND NOTICE OF EGM. Source
Sep 28, 2025Financings
Share or debt issue: COMPLETION OF SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE. Source
Sep 15, 2025Financings
Share or debt issue: SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE. Source
Aug 27, 2025Financings
Share or debt issue: (1) COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE; (2) CONTINUING CONNECTED TRANSACTION PURSUANT TO RULE 14A.60(1) OF THE LISTING RULES; AND (3) APPOINTMENT OF NON-EXECUTIVE DIRECTOR AND NOMINATION AND CORPORATE GOVERNANCE COMMITTEE MEMBER. Source
Aug 13, 2025Listings
Trading status: EXCHANGE NOTICE - RESUMPTION OF TRADING. Source
Aug 12, 2025Listings
Trading status: SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. Source
Aug 12, 2025Listings
Trading status: TRADING HALT. Source
Aug 12, 2025Listings
Trading status: EXCHANGE NOTICE - TRADING HALT. Source
Jun 6, 2025Financings
Share or debt issue: (1) PROPOSED GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; AND (4) NOTICE OF AGM. Source
Feb 25, 2025Mergers
Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION IN RELATION TO THE EARLY TERMINATION OF A LEASE AGREEMENT. Source

Press releases

Headlines of CANbridge Pharmaceuticals's own announcements, newest first. Each opens the full release on the newswire that carried it.

Aug 31, 2026HKEXnews
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026
Aug 17, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT - NHIA REIMBURSEMENT APPROVAL OF LIVMARLI IN TAIWAN
Aug 5, 2026HKEXnews
(1) CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS; AND (2) CHANGE IN COMPOSITION OF BOARD COMMITTEES
Aug 3, 2026HKEXnews
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON AUGUST 3, 2026
Jul 30, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT - EXPANSION OF GAURUNNING (VELAGLUCERASE-BETA FOR INJECTION) INTO NORTH AFRICAN MARKET
Jul 15, 2026HKEXnews
WuXi Biologics Service Procurement Framework Agreement
Jul 15, 2026HKEXnews
NOTICE OF THE EXTRAORDINARY GENERAL MEETING
Jul 15, 2026HKEXnews
CONTINUING CONNECTED TRANSACTIONS - WUXI BIOLOGICS SERVICE PROCUREMENT FRAMEWORK AGREEMENT AND NOTICE OF THE EXTRAORDINARY GENERAL MEETING
Jul 9, 2026HKEXnews
DELAY IN DESPATCH OF CIRCULAR
Jun 23, 2026HKEXnews
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 23, 2026
Jun 16, 2026HKEXnews
CONTINUING CONNECTED TRANSACTIONS: WUXI BIOLOGICS SERVICE PROCUREMENT FRAMEWORK AGREEMENT AND BAHEAL MEDICAL SERVICE PROCUREMENT FRAMEWORK AGREEMENT
Jun 2, 2026HKEXnews
NOTICE OF AGM
Jun 2, 2026HKEXnews
(1) PROPOSED GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; (4) PROPOSED GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS; AND (5) NOTICE OF AGM
Apr 12, 2026HKEXnews
GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS
Mar 30, 2026HKEXnews
RESIGNATION OF JOINT COMPANY SECRETARY AND CHANGE OF AUTHORISED REPRESENTATIVE AND PROCESS AGENT
Mar 30, 2026HKEXnews
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025
Mar 10, 2026HKEXnews
CONTINUING CONNECTED TRANSACTIONS PURSUANT TO RULE 14A.60(1) OF THE LISTING RULES
Mar 10, 2026HKEXnews
COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE
Feb 20, 2026HKEXnews
SUPPLEMENTAL ANNOUNCEMENT REGARDING THE GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS
Feb 15, 2026HKEXnews
SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:1228 on TradingView.

Listing details

Company: CANbridge Pharmaceuticals Inc.
Ticker: 1228
Listing: HKEX
Country or territory: China
Business scope: Pharmaceuticals: Major
ISIN: KYG1821D1097
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction